🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#GUTAbstract by Zhang & Terry Cheuk-Fung Yip on "Clinical care pathway to detect advanced liver disease in patients with type 2 diabetes through automated fibrosis score calculation..." via bit.ly/49b1uz4 Paper: bit.ly/49aAArq Grace Wong Lee-Ling Lim Vincent Wong

Today at The Liver Meeting… Our Laia Abad elegantly presents one of her PhD projects on the role of hepatocyte derived vesicles as novel mediators of #liver endothelial dysfunction in CLD Well done Laia Abad-Jordà !!! 👏🏼 #TLM2023

Join us on the 30. November 2023 for our Symposium "2023 a pivotal year for NASH" you find the agenda here: swissnashfoundation.org/events/ #nash #nafld #LiverTwitter #LiverX

The registration is open for the upcoming virtual symposium „2023 - a pivotal year for NASH“ please join us for talks and discussions with international experts! #NASH #NAFLD #LiverTwitter healthbook.org/webinars/virtu…

Impressive review of trial and real life data on systemic therapy options for HCC by ⁦Anna Saborowski⁩ at the ⁦SASL⁩. Brilliant!

not even 2 hours till our NASH Symposium healthbook.org/webinars/virtu… #NASH #NAFLD #LiverTwitter

Obese diabetes patients with [non-alcoholic] fatty liver disease and related chronic liver disease ask me if they have to avoid "rice" from their diet. We are a predominantly rice consuming population, which means, there will be great inertia about getting rice out of the daily

Merry Xmas and happy and healthy holidays to all of you 🤶

We wish you a healthy and happy new year! #livertwitter

Free Debrief on HCC with Anna Saborowski, K. Kelley, R. Finn, R. Lencioni, P. Galle on 29th of February Program&registration l1nq.com/188kp Foundation Cancer du Foie

A pleasure to give the annual prize of the Swiss Foundation against Liver Cancer to Dr Melloul and Dr Martin for their work on HCC burden and liver resection. ⁦Emmanuel Melloul⁩ ⁦Foundation Cancer du Foie⁩ ⁦CHUV / Centre hospitalier universitaire vaudois⁩

#BREAKING It is a big day for the Liver Community! Madrigal is proud to announce the first and only U.S. FDA-approved therapy in NASH/MASH. Learn more here: bit.ly/3Pmyqwr #FDAApproval #NASH

#GUTImages from the paper by Angelo Armandi, MD, PhD et al on "Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease" via bit.ly/49y90Dd Dina Tiniakos Luca Valenti Luca Miele @hanneshagstrom Manuel Romero-Gómez

Barcelona is walking the walk and getting in their steps today! A great way to experience Barcelona following a fantastic NIT Summit and SLD Think-Tank the last 2 days. Congratulations to Jeffrey V. Lazarus Lazarus and Jörn Schattenberg, the amazing faculty and all the participants that

Glucagon-like peptide-1 receptor agonists and risk of major adverse liver outcomes in patients with chronic liver disease and type 2 diabetes | Gut gut.bmj.com/content/73/5/8…

Read the new BSG #GUTGuideline by Suddle et al entitled "British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults" via bit.ly/3UudyX8 Dina Tiniakos #HCC

1) Our manuscript entitled « Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments” was recently released in Gut gut.bmj.com/content/early/… Claudia Campani @CRCordeliers Sandra Rebouissou GUTJournal_BMJ Theo Hirsch Sandrine Imbeaud

One of the reasons why it is so difficult to maintain weight loss is because adipose issue retains an epigenetic memory of obesity after weight loss. nature.com/articles/s4158…